These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 104330)
41. Absence of relationship between antiarrhythmic effects of antidepressant drugs and lipid peroxidation. Bril A; Abadie C; Ben Baouali A; Maupoil V; Rochette L Pharmacology; 1993; 46(1):23-32. PubMed ID: 8434029 [TBL] [Abstract][Full Text] [Related]
42. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway. Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557 [TBL] [Abstract][Full Text] [Related]
43. A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients. Amin M; Brahm E; Bronheim LA; Klingner A; Ban TA; Lehmann HE Curr Ther Res Clin Exp; 1973 Oct; 15(10):691-9. PubMed ID: 4201313 [No Abstract] [Full Text] [Related]
44. Clinical profile and serum concentration of viloxazine as compared to amitriptyline. Müller-Oerlinghausen B; Rüther E Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):321-37. PubMed ID: 386390 [TBL] [Abstract][Full Text] [Related]
45. [Double-blind comparative study on the effects of lofepramine and amitriptyline in depressive outpatients (author's transl)]. Wright S; Herrmann L Arzneimittelforschung; 1976; 26(6):1167-9. PubMed ID: 786313 [TBL] [Abstract][Full Text] [Related]
46. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial. Wheatley D Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():77-80. PubMed ID: 9342764 [TBL] [Abstract][Full Text] [Related]
47. Adrenergic and serotonergic mechanisms in depression and their response to amitriptyline. Coppen A; Wood K Ciba Found Symp; 1979; (74):157-66. PubMed ID: 261682 [TBL] [Abstract][Full Text] [Related]
49. [Grapefruit juice as a contraindication? An approach in psychiatry]. Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P Encephale; 1999; 25(1):67-71. PubMed ID: 10205736 [TBL] [Abstract][Full Text] [Related]
50. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study. Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180 [TBL] [Abstract][Full Text] [Related]
51. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Wilde MI; Benfield P Drugs; 1995 Mar; 49(3):411-39. PubMed ID: 7774514 [TBL] [Abstract][Full Text] [Related]
52. Influence of age on the parasympatholytic property of tricyclic antidepressants. Lehofer M; Moser M; Hoehn-Saric R; McLeod D; Hildebrandt G; Egner S; Steinbrenner B; Liebmann P; Zapotoczky HG Psychiatry Res; 1999 Feb; 85(2):199-207. PubMed ID: 10220010 [TBL] [Abstract][Full Text] [Related]
53. Psychometric assessment of the therapeutic efficiency of antidepressant agents. Elwan O; Souief M; Hassan MA; Allam M J Int Med Res; 1976; 4(2):118-24. PubMed ID: 16794 [TBL] [Abstract][Full Text] [Related]
54. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls. Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713 [TBL] [Abstract][Full Text] [Related]
55. Antidepressant drugs and migraine. Martucci N; Manna V; Agnoli A Cephalalgia; 1985 May; 5 Suppl 2():225-8. PubMed ID: 3893738 [TBL] [Abstract][Full Text] [Related]
56. Urinary MHPG and clinical response to amitriptyline in depressed patients. Spiker DG; Edwards D; Hanin I; Neil JF; Kupfer DJ Am J Psychiatry; 1980 Oct; 137(10):1183-7. PubMed ID: 7416262 [TBL] [Abstract][Full Text] [Related]
57. Tryptophan and Kynurenine Metabolites: Are They Related to Depression? Pompili M; Lionetto L; Curto M; Forte A; Erbuto D; Montebovi F; Seretti ME; Berardelli I; Serafini G; Innamorati M; Amore M; Baldessarini RJ; Girardi P; Simmaco M Neuropsychobiology; 2019; 77(1):23-28. PubMed ID: 30110684 [TBL] [Abstract][Full Text] [Related]
58. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275 [TBL] [Abstract][Full Text] [Related]
59. Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation. Reininghaus B; Riedrich K; Dalkner N; Bengesser SA; Birner A; Platzer M; Hamm C; Gostner JM; Fuchs D; Reininghaus EZ Psychoneuroendocrinology; 2018 Aug; 94():25-30. PubMed ID: 29753175 [TBL] [Abstract][Full Text] [Related]